43 results on '"Yokoyama, Seiya"'
Search Results
2. Exercise Suppresses Head and Neck Squamous Cell Carcinoma Growth via Oncostatin M
3. Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis
4. An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
5. One-hundred-nm-scale electronic structure and transport calculations of organic polymers on the K computer
6. PCP4/PEP19 downregulates neurite outgrowth via transcriptional regulation of Ascl1 and NeuroD1 expression in human neuroblastoma M17 cells
7. Novel linear algebraic theory and one-hundred-million-atom quantum material simulations on the K computer
8. Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1
9. Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor
10. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens
11. Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma
12. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines
13. Identification of Neck Lymph Node Metastasis-Specific microRNA—Implication for Use in Monitoring or Prediction of Neck Lymph Node Metastasis.
14. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel
15. Distribution and favorable prognostic implication of genomicEGFRalterations inIDH‐wildtype glioblastoma
16. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines.
17. Distribution and favorable prognostic implication of genomic EGFR alterations in IDH‐wildtype glioblastoma.
18. Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
19. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel
20. A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach
21. Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
22. A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
23. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression
24. Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning
25. The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5' CpG island of mucin in cancer cells
26. Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis
27. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression is associated with vessel invasion and shortened survival
28. Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury
29. PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells
30. Erratum: Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1
31. Significant photoresponsivity enhancement of polycrystalline BaSi2 films formed on heated Si(111) substrates by sputtering
32. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer
33. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
34. A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
35. Abstract 1897: Application of a novel DNA methylation analysis method (MSE) for mucin expression in pancreatic juices for diagnosis of pancreatic neoplasms
36. Pathobiological Implications of Mucin (MUC) Expression in the Outcome of Small Bowel Cancer
37. Diagnosis of Pancreatic Neoplasms Using a Novel Method of DNA Methylation Analysis of Mucin Expression in Pancreatic Juice
38. MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric Cancer
39. Expression of MUC17 Is Regulated by HIF1α-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer
40. Epigenetic regulation of mucin genes in human cancers
41. Abstract 82: Expression of MUC17, a marker of pancreatic cancer, is under the control of epigenetic modifications
42. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression
43. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.